Lynette Arnell, Author at

DHC Group and Intouch Group Publish Whitepaper on the Effect of COVID-19 on Pharmaceutical Marketing

NEW YORK, June 2, 2020 /PRNewswire/ — The DHC Group and Intouch Group announced that, together, they published a whitepaper

DHC Group and Intouch Group Publish Whitepaper on the Effect of COVID-19 on Pharmaceutical Marketing

https://pharmaphorum.com/partner-content/press-releases/dhc-group-and-intouch-group-publish-whitepaper-on-the-effect-of-covid-19-on-pharmaceutical-marketing/

The RARE Youth Revolution has begun

RARE Revolution Magazine proudly launches dedicated RARE youth online platform Powering up the voices of the youth rare disease community

The RARE Youth Revolution has begun

https://pharmaphorum.com/partner-content/the-rare-youth-revolution-has-begun/

Healthware Group announces the acquisition of pharmaphorum

Deal combines Healthware’s next-gen health consulting and full-service agency capabilities with pharmaphorum’s content-driven stakeholder engagement and publications. International

Healthware Group announces the acquisition of pharmaphorum

https://pharmaphorum.com/partner-content/healthware-group-announces-acquisition-pharmaphorum/

Vaccines trials in the COVID-19 era and tech’s role in speeding studies

Overview The COVID-19 outbreak has exposed the challenges pharmaceutical companies face as they race to develop a coronavirus

Vaccines trials in the COVID-19 era and tech’s role in speeding studies

https://pharmaphorum.com/r-d/vaccines-trials-covid-19-coronavirus/

Writer

This is an exciting opportunity to join a high growth digital media company, which has both online publications

Writer

https://pharmaphorum.com/jobs/writer-publishing-division/

Rethinking adherence programmes

How digital technologies and behavioural science create adherence programmes that work at scale. Developing drugs is only half

Rethinking adherence programmes

https://pharmaphorum.com/views-analysis-digital/rethinking-adherence-programmes/

Brexit and beyond: the challenges ahead for pharma

Brexit, and the political fallout from approving any deal, will continue to dominate British politics in 2019. It

Brexit and beyond: the challenges ahead for pharma

https://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/

The patient voice: A call to action

On December 13th 2016 the 21st Century Cures Act (Cures Act) was signed into law in the US.

The patient voice: A call to action

https://pharmaphorum.com/views-analysis-patients/patient-voice-call-action/

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

This article is the first in a series of three from Osprey Health Consulting that address the contemporary

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

https://pharmaphorum.com/views-analysis-sales-marketing/strategic-planning-increasingly-complex-uncertain-markets/

Trending

About Lynette Arnell

Posts by Lynette Arnell:

DHC Group and Intouch Group Publish Whitepaper on the Effect of COVID-19 on Pharmaceutical Marketing

The RARE Youth Revolution has begun

Healthware Group announces the acquisition of pharmaphorum

Vaccines trials in the COVID-19 era and tech’s role in speeding studies

Writer

Rethinking adherence programmes

Brexit and beyond: the challenges ahead for pharma

The patient voice: A call to action

Strategic planning in increasingly complex and uncertain markets, the David Cassidy dilemma

Search

Advanced Search

Trending

About Lynette Arnell

Posts by Lynette Arnell: